journal article·2025-03-19

X-ray Induced Persistent Type I Photodynamic Therapy with Enhanced Hypoxia Tolerance and Chemoradiotherapy

Wei Cheng, Shuai He, Qiushui Chen, Xiaorong Song, Chunhua Lu, Huanghao Yang

Nano Letters· Volume 25· Issue 11
Publisher page

Abstract

The hypoxic tumor microenvironment (TME), inadequate penetration depth of Vis/NIR light, and lack of sustaining reactive oxygen species (ROS) production capability of photosensitizers pose significant obstacles to the widespread clinic applications of photodynamic therapy (PDT). Herein, we developed a “persistent type I X-PDT” platform to simultaneously overcome these three limitations. Such a nanoplatform could generate efficient ROS ( • OH and O 2 •– ) under X-ray irradiation in both normoxic and hypoxic environments. The ROS production persists in tumor cells for more than 4 h, even after the X-ray source is removed. Notably, the persistent type I X-PDT does not increase the levels of hypoxia-inducible factor-1 alpha (HIF-1α) and vascular endothelial growth factor (VEGF) in tumor cells both in vitro and in vivo . Moreover, to further enhance the radiotherapy efficacy in hypoxic conditions, a Pt (IV) prodrug was also introduced, which can be reduced to cisplatin selectively in tumor cells, functioning not only as a chemodrug but also as a radiosensitizer.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Photoacoustic and Ultrasonic Imaging

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

New Cornerstone Science Laboratory, MOE Key Laboratory for Analytical Science of Food Safety and Biology, College of Chemistry

Fuzhou University

Department of Chemical and Biomolecular Engineering

National University of Singapore

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China

References (50)

Show source-provided references
1. 10.1021/acsmaterialslett.3c0093310.1021/acsmaterialslett.3c00933 ↗
2. 10.1039/D4TB00099D10.1039/D4TB00099D ↗
3. 10.1002/adma.20180200610.1002/adma.201802006 ↗
4. 10.1002/anie.20160413010.1002/anie.201604130 ↗
5. 10.1016/j.cej.2022.14122410.1016/j.cej.2022.141224 ↗
6. 10.1021/jacs.0c0073410.1021/jacs.0c00734 ↗
7. 10.1002/adma.20230524310.1002/adma.202305243 ↗
8. 10.1038/ncomms178610.1038/ncomms1786 ↗
9. 10.1016/j.nantod.2022.10137610.1016/j.nantod.2022.101376 ↗
10. 10.1016/S1535-6108(04)00115-110.1016/S1535-6108(04)00115-1 ↗
11. 10.1016/S0167-8140(03)00011-210.1016/S0167-8140(03)00011-2 ↗
12. 10.1016/j.immuni.2020.05.00110.1016/j.immuni.2020.05.001 ↗
13. 10.3389/fcell.2021.72996510.3389/fcell.2021.729965 ↗
14. 10.1002/anie.20230035610.1002/anie.202300356 ↗
15. 10.1186/s12917-021-02924-810.1186/s12917-021-02924-8 ↗
16. 10.1021/acsnano.4c0317210.1021/acsnano.4c03172 ↗
17. 10.1021/jacs.3c1438710.1021/jacs.3c14387 ↗
18. 10.1021/cr500419810.1021/cr5004198 ↗
19. 10.1002/smll.20150192310.1002/smll.201501923 ↗
20. 10.1039/D2NR01847K10.1039/D2NR01847K ↗
21. 10.1002/adfm.20150480310.1002/adfm.201504803 ↗
22. 10.1038/ncomms978510.1038/ncomms9785 ↗
23. 10.1021/acsnano.9b0108710.1021/acsnano.9b01087 ↗
24. 10.1002/adma.20140514110.1002/adma.201405141 ↗
25. 10.1039/C7NH00087A10.1039/C7NH00087A ↗
26. 10.1038/s41467-020-15591-410.1038/s41467-020-15591-4 ↗
27. 10.1039/D1QM01475G10.1039/D1QM01475G ↗
28. 10.1016/j.cej.2018.07.04910.1016/j.cej.2018.07.049 ↗
29. 10.1016/j.canlet.2014.12.05210.1016/j.canlet.2014.12.052 ↗
30. 10.1021/acsnano.8b0785210.1021/acsnano.8b07852 ↗
31. 10.1038/s41467-024-46768-w10.1038/s41467-024-46768-w ↗
32. 10.1002/adma.20210397810.1002/adma.202103978 ↗
33. 10.1002/adma.20210362710.1002/adma.202103627 ↗
34. 10.1038/s41467-023-41389-110.1038/s41467-023-41389-1 ↗
35. 10.1002/anie.20240439510.1002/anie.202404395 ↗
36. 10.1002/adfm.20200116610.1002/adfm.202001166 ↗
37. 10.1021/acsnano.2c0728610.1021/acsnano.2c07286 ↗
38. 10.1016/j.cej.2022.13732010.1016/j.cej.2022.137320 ↗
39. 10.1002/adma.20200788810.1002/adma.202007888 ↗
40. Liu J. · 2025 · 50710.1002/9783527845347.ch15 ↗
41. 10.1021/acsnano.6b0140110.1021/acsnano.6b01401 ↗
42. 10.1038/nnano.2015.1710.1038/nnano.2015.17 ↗
43. 10.1021/ja304986t10.1021/ja304986t ↗
44. 10.1126/sciadv.aba300910.1126/sciadv.aba3009 ↗
45. 10.3390/ijms2206314010.3390/ijms22063140 ↗
46. 10.1038/s41586-021-03251-610.1038/s41586-021-03251-6 ↗
47. 10.1021/acs.nanolett.0c0494010.1021/acs.nanolett.0c04940 ↗
48. 10.1021/acsami.8b0001510.1021/acsami.8b00015 ↗
49. 10.1016/j.actbio.2022.10.04910.1016/j.actbio.2022.10.049 ↗
50. 10.1126/sciadv.abc526710.1126/sciadv.abc5267 ↗